GoKawiilPharma companies increase investment in protein-degrader drug development
Major pharmaceutical companies are directing billions of dollars toward developing 'protein degrader' drugs, a class of medicines designed to eliminate disease-causing proteins inside cells that have traditionally been difficult to target with conventional treatments. Early-stage research suggests these drugs can effectively break down proteins previously considered 'undruggable' using standard small-molecule or antibody approaches.